✦ LIBER ✦

Polymorphisms of Fractalkine receptor CX3CR1 and plasma levels of its ligand CX3CL1 in colorectal cancer patients

✍ Scribed by Jan Dimberg; Olaf Dienus; Sture Löfgren; Anders Hugander; Dick Wågsäter

Book ID: 106059406
Publisher: Springer
Year: 2007
Tongue: English
Weight: 139 KB
Volume: 22
Category: Article
ISSN: 0179-1958
DOI: 10.1007/s00384-007-0343-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasma levels of receptor activator of n

Plasma levels of receptor activator of nuclear factor-κB ligand and osteoprotegerin in patients with neuroblastoma

✍ Donatella Granchi; Alberto Garaventa; Ilaria Amato; Paolo Paolucci; Nicola Baldi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 141 KB

## Abstract Earlier reports showed that the balance between receptor activator of nuclear factor‐κB ligand (RANKL) and its decoy‐receptor osteoprotegerin (OPG) plays an important role in the pathogenesis of metastatic osteolysis induced by neuroblastoma cells. In this study, we investigated whether

Detection of free-circulating tumor-asso

Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis

✍ Thierry Lecomte; Anne Berger; Franck Zinzindohoué; Stéphanie Micard; Bruno Landi 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 146 KB 👁 1 views

## Abstract Tumor cells are characterized by specific genetic alterations. When such genetic alterations are identified in body fluid including plasma, regardless of the presence of detectable tumor cells, it shows the existence of free‐circulating tumor‐associated DNA. The objective of our study w

Use of plasma MMP-2 and MMP-9 levels as

Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients

✍ Matthew G. Tutton; Mark L. George; Suzanne A. Eccles; Sarah Burton; R. Ian Swift 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 203 KB 👁 1 views

Matrix metalloproteinases, and notably the gelatinases MMP-2 and MMP-9, have important roles in tumour invasion, metastasis and angiogenesis. Our study investigates the distribution of MMP-2 and MMP-9 in colorectal cancer, the correlation with plasma levels, changes following surgical resection and

Microvessel density and the association

Microvessel density and the association with single nucleotide polymorphisms of the vascular endothelial growth factor receptor 2 in patients with colorectal cancer

✍ Torben Frøstrup Hansen; Flemming Brandt Sørensen; Karen-Lise Garm Spindler; Dort 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 226 KB

Plasma Levels of Matrix Metalloproteinas

Plasma Levels of Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinase-1 Correlate With Disease Stage and Survival in Colorectal Cancer Patients

✍ Erwin T. Waas; Thijs Hendriks; Roger M. L. M. Lomme; Theo Wobbes 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 225 KB

Plasma levels of vascular endothelial gr

Plasma levels of vascular endothelial growth factor (VEGF) and its receptor, flt-1, in haematological cancers: A comparison with breast cancer

✍ Funmi M. Belgore; Gregory Y. H. Lip; David Bareford; Martin Wadley; Paul Stonela 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 29 KB 👁 2 views

Raised plasma VEGF is found in some cancers but levels of its receptor soluble Flt-1 (sFlt-1) are unreported. Hypothesising increased levels to be present in haematological cancers, we measured both by ELISA in 22 patients with haematological cancer, 22 with breast cancer, and in age-and sex-matched